Home > Press > Advance Nanotech Retains Investor Relations International for Strategic IR Campaign
Advance Nanotech, Inc. (OTCBB:AVNA), a leading provider of financing and support services to drive the commercialization of nanotechnology-related products for homeland security and display technologies, today announced that it has retained Investor Relations International (IRI) to lead an expanded shareholder communication program.
Advance Nanotech Retains Investor Relations International for Strategic IR Campaign
NEW YORK, NY | Posted on April 18th, 2007
As investor relations counsel for Advance Nanotech, Los Angeles-based IRI will raise investor awareness of the company's performance through print and electronic media as well as direct communication with money managers and current or prospective shareholders. The IRI program, focused on Advance Nanotech's outlook and the execution of its growth strategy, seeks to expand the company's capital resources by broadening the company's shareholder base as well as cementing the long-term loyalty of current shareholders.
"We are pleased to have Investor Relations International working with us to raise our profile and make the broad investment community fully understand our exciting growth prospects," said Tony Goncalves, CEO of Advance Nanotech. "Our company is at a pivotal point in its history, with its first product now generating revenue in the homeland security market and a potentially lucrative portfolio of other products nearing commercialization. IRI's well-known expertise in explaining corporate strategies effectively and in generating both liquidity and shareholder value will serve us well."
To be added to Advance Nanotech's investor e-mail lists, please contact Haris Tajyar at .
About Advance Nanotech, Inc.
Advance Nanotech, Inc. identifies patented, patent-pending and proprietary technologies at leading universities and funds the additional development of such technologies in exchange for the exclusive rights to commercialize any resulting products. The company has interests in nanotechnologies that are grouped into two operating subsidiaries: Advance Display Technologies plc, which is listed on the PLUS-Quoted market in London (ADTP) and Advance Homeland Security plc.
By partnering with universities and leveraging the infrastructure and multi-disciplinary human resources of its university partners, Advance Nanotech reduces its cost base and mitigates risk. After prototypes are proven within the lab and the company develops a product roadmap and business plan, it forms majority-owned subsidiaries around the specific technology. It seeks to return value to shareholders through the sale or licensing of the technology, by securing additional financing for the subsidiary from either the venture capital community or the capital markets, or by successfully executing its business plan and consolidating its income as the majority shareholder. For more information on Advance Nanotech, please visit http://www.advancenanotech.com .
About Investor Relations International
Investor Relations International (IRI), based in Los Angeles, is a leading investor relations firm serving a worldwide client base. The principals of IRI have developed award-winning investor relations programs for a number of NYSE and Nasdaq-listed companies such as Insmed Inc., Internet Capital Group, LJ International, Starwood Hotels & Resorts Worldwide, ValueVision International and others, and have assisted dozens of public companies ranging from emerging small-cap companies to multinational corporations with market capitalizations in excess of $15 billion. IRI designs and implements customized investor relations programs to meet each client’s unique needs. It enjoys one of the highest client retention rates in the industry.
For more information on IRI, please visit the Company’s website at http://www.irintl.com .
Forward-looking statements: This news release contains forward-looking statements within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. These statements are based upon our current expectations and speak only as of the date hereof. Our actual results may differ materially and adversely from those expressed in any forward-looking statements as a result of various factors and uncertainties, including the recent economic slowdown affecting technology companies, the future success of our scientific studies, our ability to successfully develop products, rapid technological change in our markets, changes in demand for our future products, legislative, regulatory and competitive developments and general economic conditions. Our Annual Report on Form 10-K and 10-K/A, recent and forthcoming Quarterly Reports on Form 10-Q and 10-Q/A, recent Current Reports and other SEC filings discuss some of the important risk factors that may affect our business, results of operations and financial condition. We undertake no obligation to revise or update publicly any forward-looking statements for any reason.
For more information, please click here
Advance Nanotech, Inc.
Tom Black, 212-583-0080
Copyright © Business Wire 2007
If you have a comment, please Contact
Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
Malaysian Nanotechnology Company Nanopac Innovation Ltd. lists on the NSX January 19th, 2015
Aspen Aerogels, Inc. to Present at the Needham Growth Conference January 8th, 2015
Blend Therapeutics Secures $21 Million Financing and Unveils Novel Pentarin™ Platform for Cancer Therapeutics: Company’s Technology and Expertise in Cancer R&D Evolve to Create New Class of Miniaturized Biologic Drug Conjugates (mBDCs) Encapsulated in Nanoparticles January 8th, 2015
Nanometrics to Announce Fourth Quarter and Full Year Financial Results on February 2, 2015 January 7th, 2015
Iranian Researchers Planning to Produce Edible Insulin January 28th, 2015
Nanoparticles that deliver oligonucleotide drugs into cells described in Nucleic Acid Therapeutics January 28th, 2015
'Bulletproof' battery: Kevlar membrane for safer, thinner lithium rechargeables January 28th, 2015
Spider electro-combs its sticky nano-filaments January 28th, 2015
Rice's Naomi Halas to direct Smalley Institute: Optics pioneer will lead Rice's multidisciplinary science institute January 15th, 2015
SUNY Board Appoints Dr. Alain Kaloyeros as Founding President of SUNY Polytechnic Institute January 13th, 2015
Blend Therapeutics Appoints Distinguished Physician Scientist, Dennis Ausiello, MD, to Board of Directors January 8th, 2015
QD Vision Receives New Funding Round to Meet Growing Demand for Quantum Dot Technology: Industry Veteran Steve Ward Named Executive Chairman January 5th, 2015